150 related articles for article (PubMed ID: 35043292)
1. Editorial Comment: Radiomics analysis allows for precise prediction of silent corticotroph adenoma among non-functioning pituitary adenomas.
Bourbonne V
Eur Radiol; 2022 Mar; 32(3):1475-1476. PubMed ID: 35043292
[No Abstract] [Full Text] [Related]
2. Radiomics analysis allows for precise prediction of silent corticotroph adenoma among non-functioning pituitary adenomas.
Rui W; Qiao N; Wu Y; Zhang Y; Aili A; Zhang Z; Ye H; Wang Y; Zhao Y; Yao Z
Eur Radiol; 2022 Mar; 32(3):1570-1578. PubMed ID: 34837512
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of silent corticotroph adenomas.
Alahmadi H; Lee D; Wilson JR; Hayhurst C; Mete O; Gentili F; Asa SL; Zadeh G
Acta Neurochir (Wien); 2012 Aug; 154(8):1493-8. PubMed ID: 22619024
[TBL] [Abstract][Full Text] [Related]
4. Radiomics model and clinical scale for the preoperative diagnosis of silent corticotroph adenomas.
Wang H; Chang J; Zhang W; Fang Y; Li S; Fan Y; Jiang S; Yao Y; Deng K; Lu L; Bao X; Feng F; Wang R; Feng M
J Endocrinol Invest; 2023 Sep; 46(9):1843-1854. PubMed ID: 37020103
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 as a marker distinguishing functioning from silent corticotroph adenomas.
Thodou E; Argyrakos T; Kontogeorgos G
Hormones (Athens); 2007; 6(3):227-32. PubMed ID: 17724007
[TBL] [Abstract][Full Text] [Related]
6. Clinical Relevance and Immunohistochemical Patterns of Silent Pituitary Adenomas: 10 Years of Single-centre Experience.
Akkus G; Karagun B; Çetinalp NE; Açıkalın A; Evran M; Sengöz S; Sert M; Zorludemir S; Tetiker T
Curr Med Imaging; 2021; 17(2):310-317. PubMed ID: 33357196
[TBL] [Abstract][Full Text] [Related]
7. ACTH adenomas transforming their clinical expression: report of 5 cases.
Zoli M; Faustini-Fustini M; Mazzatenta D; Marucci G; De Carlo E; Bacci A; Pasquini E; Lanzino G; Frank G
Neurosurg Focus; 2015 Feb; 38(2):E15. PubMed ID: 25639317
[TBL] [Abstract][Full Text] [Related]
8. Pediatric silent corticotroph pituitary adenoma and role for proton therapy: case report.
Prendergast N; Aldana PR; Rotondo RL; Torres-Santiago L; Beier AD
J Neurosurg Pediatr; 2018 Nov; 23(2):214-218. PubMed ID: 30497138
[TBL] [Abstract][Full Text] [Related]
9. CRH-Receptor Molecular Imaging Reveals the Intimacy of Corticotroph Adenomas.
Bertherat J
J Clin Endocrinol Metab; 2021 Mar; 106(4):e1902-e1904. PubMed ID: 33382418
[No Abstract] [Full Text] [Related]
10. Silent corticotroph adenomas: Experience with five cases.
Serra Soler G; Antich Barceló C; Mas Bonet A; Antón Valentí E; García Fernández H
Med Clin (Barc); 2021 Jun; 156(11):582-583. PubMed ID: 32513450
[No Abstract] [Full Text] [Related]
11. Silent corticotroph adenomas.
Ben-Shlomo A; Cooper O
Pituitary; 2018 Apr; 21(2):183-193. PubMed ID: 29344907
[TBL] [Abstract][Full Text] [Related]
12. Isolated double pituitary adenomas: A silent corticotroph adenoma and a microprolactinoma.
Eytan S; Kim KY; Bleich D; Raghuwanshi M; Eloy JA; Liu JK
J Clin Neurosci; 2015 Oct; 22(10):1676-8. PubMed ID: 26067545
[TBL] [Abstract][Full Text] [Related]
13. Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.
Cooper O; Ben-Shlomo A; Bonert V; Bannykh S; Mirocha J; Melmed S
Horm Cancer; 2010 Apr; 1(2):80-92. PubMed ID: 20717480
[TBL] [Abstract][Full Text] [Related]
14. Double Pituitary Adenomas with Synchronous Somatotroph and Corticotroph Clinical Presentation of Acromegaly and Cushing's Disease.
Collazo-Gutiérrez N; de Jesús O; Villamil-Jarauta M; Alvarado M; González L; Ramírez M; Carlo-Chevere VJ
World Neurosurg; 2019 Dec; 132():161-164. PubMed ID: 31505284
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas.
Tateno T; Kato M; Tani Y; Oyama K; Yamada S; Hirata Y
Endocr J; 2009; 56(4):579-84. PubMed ID: 19318729
[TBL] [Abstract][Full Text] [Related]
16. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
[TBL] [Abstract][Full Text] [Related]
17. Progression rate of silent corticotroph adenomas after stereotactic radiosurgery. In regard to Xu et al.
Chen SC; Chung WY
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1113-4. PubMed ID: 25832706
[No Abstract] [Full Text] [Related]
18. Prevalence of clinically silent corticotroph macroadenomas.
Guttenberg KB; Mayson SE; Sawan C; Kharlip J; Lee JY; Martinez-Lage M; Loevner LA; Ewanichak J; Grady MS; Snyder PJ
Clin Endocrinol (Oxf); 2016 Dec; 85(6):874-880. PubMed ID: 27346850
[TBL] [Abstract][Full Text] [Related]
19. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
Rak B; Maksymowicz M; Pękul M; Zieliński G
Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
[TBL] [Abstract][Full Text] [Related]
20. Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas.
Hanson JM; Mol JA; Leegwater PA; Bilodeau S; Drouin J; Meij BP
Domest Anim Endocrinol; 2008 Apr; 34(3):217-22. PubMed ID: 17544240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
